Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Horwath-Winter: Iodide iontophoresis as a treatment for dry eye syndrome. (0.11 sec) 

Iodide iontophoresis as a treatment for dry eye syndrome

- nih.gov - Free from Publisher
J Horwath-Winter, O Schmut, EM Haller- … - British Journal of Ophthalmology, 2005 - bjo.bmj.com
Background/aims: Among the causes related to the development or perpetuation and
aggravation of dry eye disease, oxidative reactions may have a role in the
pathogenesis of this disorder. Antioxidants, such as iodide, have shown a ...
Cited by 6 - Related articles - All 9 versions

[PDF] Traitements de l'œil sec: quelles données justifient notre pratique?


M Labetoulle - RéfleXions - reflexionsophtalmologiques.com
33 N 106-Tome 12-juin 2007-RéfleXions Ophtalmologiques Sur face Oculair e
••••• La sécheresse oculaire: un enjeu de santé publique et un enjeu
économique La sécheresse oculaire est une des pathologies ophtalmiques ...
Related articles - View as HTML - All 8 versions

[DOC] MEDICAL MANAGEMENT: MISCELLANEOUS MODALITIES


SIA AGARWAL, AA MD, SA MD, SJ MD, HP … - ascrs.org
Over ten million Americans suffer from dry eyes. Many different factors
contribute to dry eye syndrome. It is usually caused by a problem with the
quality of the tear film that lubricates the eyes. The tear film is ...
Related articles - View as HTML - All 2 versions

Ocular delivery of acetylsalicylic acid by repetitive coulomb-controlled iontophoresis


MT Kralinger, M Voigt, GF Kieselbach, D … - Ophthalmic research, 2003 - content.karger.com
Martina T. Kralingera,b Monika Voigta,c Gerhard F. Kieselbacha,b Duco Hamasakia
Brandy C. Haydena Jean-Marie Parela,d,e ... Received: June 18, 2002 Accepted
after revision: November 28, 2002 ... J.-M. Parel, PhD Ophthalmic ...
Cited by 14 - Related articles - BL Direct - All 5 versions

Efficacy of iontophoresis in the rat cornea


J Frucht-Pery, A Solomon, R Doron, P Ever- … - Graefe's Archive for Clinical and Experimental …, 1996 - Springer
Page 1. Graefe's Arch Clin Exp Ophthalmol (1996) 234:765-769 © Springer-Verlag
1996 Joseph Frucht-Pery Arieh Solomon Ran Doron Pnina ...
Cited by 8 - Related articles - BL Direct - All 3 versions

Anti-oxidative capacity of various artificial tear preparations


G Rieger - Graefe's Archive for Clinical and Experimental …, 2001 - Springer
Abstract Background: Increased UV radiation and ozone exposure may cause “dry
eyes of environmen- tal origin”, if the normal anti-oxida- tive capacity of
the tear film can no longer cope with the oxidative stress. The use of ...
Cited by 8 - Related articles - BL Direct - All 5 versions

Role of erythrocytes in thromboembolism pathology


JL Wautier - Annales de médecine interne, 1986 - ncbi.nlm.nih.gov
The association of erythrocyte disorders and thrombosis in polycythemia vera,
paroxysmal nocturnal hemoglobinuria (PNH) and sickle cell anemia suggest that
erythrocyte abnormality, could be involved in the genesis of thrombosis. A ...
Cited by 1 - Related articles

Basic and clinical aspects of gene therapy for retinopathy induced by diabetes


JHY Ting, DK Martin - Current gene therapy, 2006 - ingentaconnect.com
Abstract: Diabetes mellitus invariably induces retinopathy which causes a loss
of vision that is the major cause of blind- ness in people of working age across
most ethnic groups. Although there have been major advances in gene therapy ...
Cited by 1 - Related articles - BL Direct - All 3 versions

Repeat expansion and phenotypic variability of Friedreich's ataxia in families of different …


I Ovchinnikov, S Illarioshkin, G Bagyeva, N … - Neuromuscular Disorders, 1997 - ingentaconnect.com
Friedreich's ataxia (FRDA) is an autosomal recessive, neurodegenerative disease
associated with unstable GAA repeat expansion in the first intron of X25 gene on
chromosome 9q13. Eleven families with 17 affec-ted patients and 25 normal ...
Cited by 1 - Related articles

[PDF] Diquafosol tetrasodium (Inspire/Allergan/Santen)


J Fischbarg - Current Opinion in Investigational Drugs, 2003 - biomedcentral.com
Inspire, in collaboration with Allergan and Santen, is developing an eye-drop
formulation of diquafosol tetrasodium (INS-365), a second-generation uridine
nucleotide analog P2Y 2 receptor agonist for the potential treatment of dry ...
Cited by 1 - Related articles - View as HTML - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google